BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6406079)

  • 1. Mouse liver microsomal cholesterol epoxide hydrolase: a specific inhibition of its activity by 5,6 alpha-Imino-5 alpha-cholestan-3 alpha-OL.
    Watabe T; Komatsu T; Isobe M; Tsubaki A
    Chem Biol Interact; 1983; 44(1-2):143-54. PubMed ID: 6406079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol alpha- and beta-epoxides as obligatory intermediates in the hepatic microsomal metabolism of cholesterol to cholestanetriol.
    Watabe T; Kanai M; Isobe M; Ozawa N
    Biochim Biophys Acta; 1980 Aug; 619(2):414-9. PubMed ID: 7407222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The obligatory intermediacy of 16,17 alpha- and 16,17 beta-epoxides in the biotransformation of androsta-5,16-dien-3 beta-ol to androst-5-ene-3 beta, 16 alpha, 17 beta- and -3 beta, 16 beta, 17 alpha-triols by male rat liver microsomes.
    Watabe T; Komatsu T; Kobayashi K; Isobe M; Ozawa N; Saitoh Y
    J Biol Chem; 1985 Jul; 260(15):8716-20. PubMed ID: 4019450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous role of microsomal epoxide hydrolase. Ontogenesis, induction inhibition, tissue distribution, immunological behaviour and purification of microsomal epoxide hydrolase with 16 alpha, 17 alpha-epoxyandrostene-3-one as substrate.
    Vogel-Bindel U; Bentley P; Oesch F
    Eur J Biochem; 1982 Aug; 126(2):425-31. PubMed ID: 7128597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct rat hepatic microsomal epoxide hydrolases catalyze the hydration of cholesterol 5,6 alpha-oxide and certain xenobiotic alkene and arene oxides.
    Levin W; Michaud DP; Thomas PE; Jerina DM
    Arch Biochem Biophys; 1983 Feb; 220(2):485-94. PubMed ID: 6401984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of environmentally encountered epoxides on mouse liver epoxide-metabolizing enzymes.
    Moody DE; Montgomery KA; Ashour MB; Hammock BD
    Biochem Pharmacol; 1991 Jun; 41(11):1625-37. PubMed ID: 2043152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of benzo[a]pyrene and aflatoxin B1 to mutagenic chemical species by microsomal preparations from rat liver and small intestine in relation to microsomal epoxide hydrolase.
    Walters JM; Combes RD
    Mutagenesis; 1986 Jan; 1(1):45-8. PubMed ID: 3125402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualization of a covalent intermediate between microsomal epoxide hydrolase, but not cholesterol epoxide hydrolase, and their substrates.
    Müller F; Arand M; Frank H; Seidel A; Hinz W; Winkler L; Hänel K; Blée E; Beetham JK; Hammock BD; Oesch F
    Eur J Biochem; 1997 Apr; 245(2):490-6. PubMed ID: 9151984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrolysis of the 2',3'-allylic epoxides of allylbenzene, estragole, eugenol, and safrole by both microsomal and cytosolic epoxide hydrolases.
    Luo G; Qato MK; Guenthner TM
    Drug Metab Dispos; 1992; 20(3):440-5. PubMed ID: 1521503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of liver microsomal cholesterol 5,6-oxide hydrolase.
    Nashed NT; Michaud DP; Levin W; Jerina DM
    Arch Biochem Biophys; 1985 Aug; 241(1):149-62. PubMed ID: 4026314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human liver cytosolic epoxide hydrolases.
    Schladt L; Thomas H; Hartmann R; Oesch F
    Eur J Biochem; 1988 Oct; 176(3):715-23. PubMed ID: 3169021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic properties and inhibition of hepatic cholesterol-epoxide hydrolase.
    Sevanian A; McLeod LL
    J Biol Chem; 1986 Jan; 261(1):54-9. PubMed ID: 3941086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition and selective induction of multiple microsomal epoxide hydrolases.
    Guenthner TM
    Biochem Pharmacol; 1986 Mar; 35(5):839-45. PubMed ID: 3954789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Existence of multiple forms of microsomal epoxide hydrolases with radically different substrate specificities.
    Oesch F; Timms CW; Walker CH; Guenthner TM; Sparrow A; Watabe T; Wolf CR
    Carcinogenesis; 1984 Jan; 5(1):7-9. PubMed ID: 6690087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of human liver cytosolic epoxide hydrolase and comparison to the microsomal enzyme.
    Wang P; Meijer J; Guengerich FP
    Biochemistry; 1982 Nov; 21(23):5769-76. PubMed ID: 6185139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential substrate selectivity of murine hepatic cytosolic and microsomal epoxide hydrolases.
    Hammock BD; Hasagawa LS
    Biochem Pharmacol; 1983 Apr; 32(7):1155-64. PubMed ID: 6847708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of modulation of microsomal epoxide hydrolase activity on microsome-catalyzed activation of benzo[alpha]pyrene and its covalent binding to DNA.
    Guenthner TM; Oesch F
    Cancer Lett; 1981 Jan; 11(3):175-83. PubMed ID: 7248922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid epoxide hydrolase in rat lung preparations.
    Sevanian A; Stein RA; Mead JF
    Biochim Biophys Acta; 1980 Aug; 614(2):489-500. PubMed ID: 7407199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K epoxide reductase activity in the metabolism of epoxides.
    Liptay-Reuter I; Dose K; Guenthner T; Wörner W; Oesch F
    Biochem Pharmacol; 1985 Aug; 34(15):2617-20. PubMed ID: 4015704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of multiple epoxide hydrolase activities in mouse liver nuclear envelope.
    Guenthner TM
    Biochem Pharmacol; 1986 Oct; 35(19):3261-6. PubMed ID: 3768020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.